Literature DB >> 7684303

Counteraction of the rapid tolerance to 8-OH-DPAT-induced corticosterone secretion in rats by activation of the GABAA receptor-chloride channel complex.

D Kelder1, S B Ross.   

Abstract

1. The effect of various classes of compounds on the rapidly developed tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)-induced corticosterone secretion was examined. 2. Compounds activating the gamma-aminobutyric acidA (GABAA) receptor-chloride complex, i.e. muscimol (3 mg kg-1), diazepam (5 mg kg-1), flunitrazepam (1 mg kg-1), sodium pentobarbitone (10-30 mg kg-1) and chlormethiazole ethane disulphonate (50 mg kg-1) counteracted the development of tolerance when injected before or simultaneously with, but not 15 min after 8-OH-DPAT. 3. At these doses the compounds produced an acute increase in serum corticosterone but had, with the exception of muscimol, no effect on the response to the challenge dose of 8-OH-DPAT 24 h later. Muscimol significantly decreased the response. 4. The GABAA chloride channel antagonist, picrotoxin (1 mg kg-1, s.c.), but not bicuculline (1 mg kg-1, i.p.) potentiated the development of tolerance to 8-OH-DPAT-induced corticosterone secretion. 5. A number of compounds with widely differing pharmacological actions were examined and found to have no effect on the development of tolerance to 8-OH-DPAT-induced corticosterone secretion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684303      PMCID: PMC2175609          DOI: 10.1111/j.1476-5381.1993.tb13555.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.

Authors:  R M Palmer; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

2.  Techniques for measuring the interaction of drugs with calmodulin.

Authors:  B Weiss
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

Authors:  C Köhler; H Hall; S O Ogren; L Gawell
Journal:  Biochem Pharmacol       Date:  1985-07-01       Impact factor: 5.858

4.  Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates.

Authors:  D M Turner; R W Ransom; J S Yang; R W Olsen
Journal:  J Pharmacol Exp Ther       Date:  1989-03       Impact factor: 4.030

5.  Chlormethiazole: neurochemical actions at the gamma-aminobutyric acid receptor complex.

Authors:  E J Moody; P Skolnick
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

6.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

7.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

8.  Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT.

Authors:  S Hjorth
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

9.  Two distinct interactions of barbiturates and chlormethiazole with the GABAA receptor complex in rat cuneate nucleus in vitro.

Authors:  N L Harrison; M A Simmonds
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

Review 10.  Calcium antagonism and calcium entry blockade.

Authors:  T Godfraind; R Miller; M Wibo
Journal:  Pharmacol Rev       Date:  1986-12       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.